aluates Reports

$ 0.0

Automative

Global Next-Generation Oncology Solution Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-37M13153

Global Next Generation Oncology Solution Market Research Report 2023

BUY CHAPTERS

Global Next-Generation Oncology Solution Market Research Report 2025

Code: QYRE-Auto-37M13153

Report

April 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Illumina Inc

PerkinElmer Inc

Thermo Fisher Scientific

Roche Holding

Agilent Technologies

GE Healthcare

Varian

Brainlab

Qiagen NV

Hologic Inc

Pacific Biosciences

Astrazeneca plc

BGI Group

Paige

Next-Generation Oncology Solution Market

The global market for Next-Generation Oncology Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Next-generation oncology solutions refer to the advanced and innovative technologies, treatments, and approaches used to diagnose, treat, and manage cancer more effectively and efficiently. These solutions aim to improve patient outcomes, enhance precision medicine, and streamline oncology care by leveraging cutting-edge technologies and personalized treatment approaches.

The global market for next-generation oncology solutions has been witnessing substantial growth and innovation, driven by advancements in genomics, precision medicine, immunotherapy, and data analytics. These cutting-edge solutions are transforming cancer care by providing more personalized and effective treatment options for patients. The rising incidence of cancer worldwide is propelling the demand for advanced oncology solutions that can offer better treatment outcomes and improved patient care. Precision medicine approaches, which use genomic testing and targeted therapies, have gained prominence, driving the adoption of next-gen oncology solutions. The United States, in particular, is a major market for next-gen oncology solutions due to its robust research and development infrastructure, extensive clinical trials, and high cancer incidence. European countries have been early adopters of precision medicine and advanced oncology treatments, contributing to the growth of the market in this region. The Asia-Pacific region is witnessing significant growth in the oncology market, with countries like China, India, and Japan investing in healthcare infrastructure and research. The global market for next-generation oncology solutions is expected to continue its growth trajectory in the coming years. As technology continues to advance, precision medicine becomes more personalized, and immunotherapy gains further momentum, next-gen oncology solutions are likely to play an increasingly significant role in cancer care. Moreover, collaborations between pharmaceutical companies, research institutions, and healthcare providers are likely to drive innovation and accelerate the development and adoption of next-gen oncology treatments worldwide.

This report aims to provide a comprehensive presentation of the global market for Next-Generation Oncology Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Oncology Solution.

The Next-Generation Oncology Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Next-Generation Oncology Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Next-Generation Oncology Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Next-Generation Oncology Solution Market Report

Report Metric	Details
Report Name	Next-Generation Oncology Solution Market
Segment by Type	Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy) Software Others
Segment by Application	Hospitals Diagnostic Imaging Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Paige, GE Healthcare, Varian, Brainlab, Qiagen, Hologic, Pacific Biosciences, AstraZeneca, BGI Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next-Generation Oncology Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Next-Generation Oncology Solution Market report?

Ans: The main players in the Next-Generation Oncology Solution Market are Illumina, PerkinElmer, Thermo Fisher Scientific, Roche Holding, Agilent Technologies, Paige, GE Healthcare, Varian, Brainlab, Qiagen, Hologic, Pacific Biosciences, AstraZeneca, BGI Group

What are the Application segmentation covered in the Next-Generation Oncology Solution Market report?

Ans: The Applications covered in the Next-Generation Oncology Solution Market report are Hospitals, Diagnostic Imaging Centers, Others

What are the Type segmentation covered in the Next-Generation Oncology Solution Market report?

Ans: The Types covered in the Next-Generation Oncology Solution Market report are Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy), Software, Others

Recommended Reports

Oncology Diagnostics

Genomics & Sequencing

Cancer Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next-Generation Oncology Solution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)

1.2.3 Software

1.2.4 Others

1.3 Market by Application

1.3.1 Global Next-Generation Oncology Solution Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostic Imaging Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next-Generation Oncology Solution Market Perspective (2020-2031)

2.2 Global Next-Generation Oncology Solution Growth Trends by Region

2.2.1 Global Next-Generation Oncology Solution Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Next-Generation Oncology Solution Historic Market Size by Region (2020-2025)

2.2.3 Next-Generation Oncology Solution Forecasted Market Size by Region (2026-2031)

2.3 Next-Generation Oncology Solution Market Dynamics

2.3.1 Next-Generation Oncology Solution Industry Trends

2.3.2 Next-Generation Oncology Solution Market Drivers

2.3.3 Next-Generation Oncology Solution Market Challenges

2.3.4 Next-Generation Oncology Solution Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next-Generation Oncology Solution Players by Revenue

3.1.1 Global Top Next-Generation Oncology Solution Players by Revenue (2020-2025)

3.1.2 Global Next-Generation Oncology Solution Revenue Market Share by Players (2020-2025)

3.2 Global Next-Generation Oncology Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Next-Generation Oncology Solution Revenue

3.4 Global Next-Generation Oncology Solution Market Concentration Ratio

3.4.1 Global Next-Generation Oncology Solution Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next-Generation Oncology Solution Revenue in 2024

3.5 Global Key Players of Next-Generation Oncology Solution Head office and Area Served

3.6 Global Key Players of Next-Generation Oncology Solution, Product and Application

3.7 Global Key Players of Next-Generation Oncology Solution, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Next-Generation Oncology Solution Breakdown Data by Type

4.1 Global Next-Generation Oncology Solution Historic Market Size by Type (2020-2025)

4.2 Global Next-Generation Oncology Solution Forecasted Market Size by Type (2026-2031)

5 Next-Generation Oncology Solution Breakdown Data by Application

5.1 Global Next-Generation Oncology Solution Historic Market Size by Application (2020-2025)

5.2 Global Next-Generation Oncology Solution Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Next-Generation Oncology Solution Market Size (2020-2031)

6.2 North America Next-Generation Oncology Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Next-Generation Oncology Solution Market Size by Country (2020-2025)

6.4 North America Next-Generation Oncology Solution Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Next-Generation Oncology Solution Market Size (2020-2031)

7.2 Europe Next-Generation Oncology Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Next-Generation Oncology Solution Market Size by Country (2020-2025)

7.4 Europe Next-Generation Oncology Solution Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Next-Generation Oncology Solution Market Size (2020-2031)

8.2 Asia-Pacific Next-Generation Oncology Solution Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Next-Generation Oncology Solution Market Size by Region (2020-2025)

8.4 Asia-Pacific Next-Generation Oncology Solution Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Next-Generation Oncology Solution Market Size (2020-2031)

9.2 Latin America Next-Generation Oncology Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Next-Generation Oncology Solution Market Size by Country (2020-2025)

9.4 Latin America Next-Generation Oncology Solution Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next-Generation Oncology Solution Market Size (2020-2031)

10.2 Middle East & Africa Next-Generation Oncology Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Next-Generation Oncology Solution Market Size by Country (2020-2025)

10.4 Middle East & Africa Next-Generation Oncology Solution Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Details

11.1.2 Illumina Business Overview

11.1.3 Illumina Next-Generation Oncology Solution Introduction

11.1.4 Illumina Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.1.5 Illumina Recent Development

11.2 PerkinElmer

11.2.1 PerkinElmer Company Details

11.2.2 PerkinElmer Business Overview

11.2.3 PerkinElmer Next-Generation Oncology Solution Introduction

11.2.4 PerkinElmer Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.2.5 PerkinElmer Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Next-Generation Oncology Solution Introduction

11.3.4 Thermo Fisher Scientific Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Roche Holding

11.4.1 Roche Holding Company Details

11.4.2 Roche Holding Business Overview

11.4.3 Roche Holding Next-Generation Oncology Solution Introduction

11.4.4 Roche Holding Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.4.5 Roche Holding Recent Development

11.5 Agilent Technologies

11.5.1 Agilent Technologies Company Details

11.5.2 Agilent Technologies Business Overview

11.5.3 Agilent Technologies Next-Generation Oncology Solution Introduction

11.5.4 Agilent Technologies Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.5.5 Agilent Technologies Recent Development

11.6 Paige

11.6.1 Paige Company Details

11.6.2 Paige Business Overview

11.6.3 Paige Next-Generation Oncology Solution Introduction

11.6.4 Paige Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.6.5 Paige Recent Development

11.7 GE Healthcare

11.7.1 GE Healthcare Company Details

11.7.2 GE Healthcare Business Overview

11.7.3 GE Healthcare Next-Generation Oncology Solution Introduction

11.7.4 GE Healthcare Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.7.5 GE Healthcare Recent Development

11.8 Varian

11.8.1 Varian Company Details

11.8.2 Varian Business Overview

11.8.3 Varian Next-Generation Oncology Solution Introduction

11.8.4 Varian Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.8.5 Varian Recent Development

11.9 Brainlab

11.9.1 Brainlab Company Details

11.9.2 Brainlab Business Overview

11.9.3 Brainlab Next-Generation Oncology Solution Introduction

11.9.4 Brainlab Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.9.5 Brainlab Recent Development

11.10 Qiagen

11.10.1 Qiagen Company Details

11.10.2 Qiagen Business Overview

11.10.3 Qiagen Next-Generation Oncology Solution Introduction

11.10.4 Qiagen Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.10.5 Qiagen Recent Development

11.11 Hologic

11.11.1 Hologic Company Details

11.11.2 Hologic Business Overview

11.11.3 Hologic Next-Generation Oncology Solution Introduction

11.11.4 Hologic Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.11.5 Hologic Recent Development

11.12 Pacific Biosciences

11.12.1 Pacific Biosciences Company Details

11.12.2 Pacific Biosciences Business Overview

11.12.3 Pacific Biosciences Next-Generation Oncology Solution Introduction

11.12.4 Pacific Biosciences Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.12.5 Pacific Biosciences Recent Development

11.13 AstraZeneca

11.13.1 AstraZeneca Company Details

11.13.2 AstraZeneca Business Overview

11.13.3 AstraZeneca Next-Generation Oncology Solution Introduction

11.13.4 AstraZeneca Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.13.5 AstraZeneca Recent Development

11.14 BGI Group

11.14.1 BGI Group Company Details

11.14.2 BGI Group Business Overview

11.14.3 BGI Group Next-Generation Oncology Solution Introduction

11.14.4 BGI Group Revenue in Next-Generation Oncology Solution Business (2020-2025)

11.14.5 BGI Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Illumina Inc

PerkinElmer Inc

Thermo Fisher Scientific

Roche Holding

Agilent Technologies

GE Healthcare

Varian

Brainlab

Qiagen NV

Hologic Inc

Pacific Biosciences

Astrazeneca plc

BGI Group

Paige

List of Tables

Table 1. Global Next-Generation Oncology Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy)

Table 3. Key Players of Software

Table 4. Key Players of Others

Table 5. Global Next-Generation Oncology Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Next-Generation Oncology Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Next-Generation Oncology Solution Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Next-Generation Oncology Solution Market Share by Region (2020-2025)

Table 9. Global Next-Generation Oncology Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Next-Generation Oncology Solution Market Share by Region (2026-2031)

Table 11. Next-Generation Oncology Solution Market Trends

Table 12. Next-Generation Oncology Solution Market Drivers

Table 13. Next-Generation Oncology Solution Market Challenges

Table 14. Next-Generation Oncology Solution Market Restraints

Table 15. Global Next-Generation Oncology Solution Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Next-Generation Oncology Solution Market Share by Players (2020-2025)

Table 17. Global Top Next-Generation Oncology Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Oncology Solution as of 2024)

Table 18. Ranking of Global Top Next-Generation Oncology Solution Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Next-Generation Oncology Solution Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Next-Generation Oncology Solution, Headquarters and Area Served

Table 21. Global Key Players of Next-Generation Oncology Solution, Product and Application

Table 22. Global Key Players of Next-Generation Oncology Solution, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Next-Generation Oncology Solution Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Next-Generation Oncology Solution Revenue Market Share by Type (2020-2025)

Table 26. Global Next-Generation Oncology Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Next-Generation Oncology Solution Revenue Market Share by Type (2026-2031)

Table 28. Global Next-Generation Oncology Solution Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Next-Generation Oncology Solution Revenue Market Share by Application (2020-2025)

Table 30. Global Next-Generation Oncology Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Next-Generation Oncology Solution Revenue Market Share by Application (2026-2031)

Table 32. North America Next-Generation Oncology Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Next-Generation Oncology Solution Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Next-Generation Oncology Solution Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Next-Generation Oncology Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Next-Generation Oncology Solution Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Next-Generation Oncology Solution Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Next-Generation Oncology Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Next-Generation Oncology Solution Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Next-Generation Oncology Solution Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Next-Generation Oncology Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Next-Generation Oncology Solution Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Next-Generation Oncology Solution Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Next-Generation Oncology Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Next-Generation Oncology Solution Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Next-Generation Oncology Solution Market Size by Country (2026-2031) & (US$ Million)

Table 47. Illumina Company Details

Table 48. Illumina Business Overview

Table 49. Illumina Next-Generation Oncology Solution Product

Table 50. Illumina Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 51. Illumina Recent Development

Table 52. PerkinElmer Company Details

Table 53. PerkinElmer Business Overview

Table 54. PerkinElmer Next-Generation Oncology Solution Product

Table 55. PerkinElmer Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 56. PerkinElmer Recent Development

Table 57. Thermo Fisher Scientific Company Details

Table 58. Thermo Fisher Scientific Business Overview

Table 59. Thermo Fisher Scientific Next-Generation Oncology Solution Product

Table 60. Thermo Fisher Scientific Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 61. Thermo Fisher Scientific Recent Development

Table 62. Roche Holding Company Details

Table 63. Roche Holding Business Overview

Table 64. Roche Holding Next-Generation Oncology Solution Product

Table 65. Roche Holding Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 66. Roche Holding Recent Development

Table 67. Agilent Technologies Company Details

Table 68. Agilent Technologies Business Overview

Table 69. Agilent Technologies Next-Generation Oncology Solution Product

Table 70. Agilent Technologies Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 71. Agilent Technologies Recent Development

Table 72. Paige Company Details

Table 73. Paige Business Overview

Table 74. Paige Next-Generation Oncology Solution Product

Table 75. Paige Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 76. Paige Recent Development

Table 77. GE Healthcare Company Details

Table 78. GE Healthcare Business Overview

Table 79. GE Healthcare Next-Generation Oncology Solution Product

Table 80. GE Healthcare Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 81. GE Healthcare Recent Development

Table 82. Varian Company Details

Table 83. Varian Business Overview

Table 84. Varian Next-Generation Oncology Solution Product

Table 85. Varian Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 86. Varian Recent Development

Table 87. Brainlab Company Details

Table 88. Brainlab Business Overview

Table 89. Brainlab Next-Generation Oncology Solution Product

Table 90. Brainlab Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 91. Brainlab Recent Development

Table 92. Qiagen Company Details

Table 93. Qiagen Business Overview

Table 94. Qiagen Next-Generation Oncology Solution Product

Table 95. Qiagen Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 96. Qiagen Recent Development

Table 97. Hologic Company Details

Table 98. Hologic Business Overview

Table 99. Hologic Next-Generation Oncology Solution Product

Table 100. Hologic Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 101. Hologic Recent Development

Table 102. Pacific Biosciences Company Details

Table 103. Pacific Biosciences Business Overview

Table 104. Pacific Biosciences Next-Generation Oncology Solution Product

Table 105. Pacific Biosciences Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 106. Pacific Biosciences Recent Development

Table 107. AstraZeneca Company Details

Table 108. AstraZeneca Business Overview

Table 109. AstraZeneca Next-Generation Oncology Solution Product

Table 110. AstraZeneca Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 111. AstraZeneca Recent Development

Table 112. BGI Group Company Details

Table 113. BGI Group Business Overview

Table 114. BGI Group Next-Generation Oncology Solution Product

Table 115. BGI Group Revenue in Next-Generation Oncology Solution Business (2020-2025) & (US$ Million)

Table 116. BGI Group Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Next-Generation Oncology Solution Picture

Figure 2. Global Next-Generation Oncology Solution Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Next-Generation Oncology Solution Market Share by Type: 2024 VS 2031

Figure 4. Equipment (High-Intensity Focused Ultrasound, Advanced Forms of Radiation Therapy) Features

Figure 5. Software Features

Figure 6. Others Features

Figure 7. Global Next-Generation Oncology Solution Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Next-Generation Oncology Solution Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Diagnostic Imaging Centers Case Studies

Figure 11. Others Case Studies

Figure 12. Next-Generation Oncology Solution Report Years Considered

Figure 13. Global Next-Generation Oncology Solution Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Next-Generation Oncology Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Next-Generation Oncology Solution Market Share by Region: 2024 VS 2031

Figure 16. Global Next-Generation Oncology Solution Market Share by Players in 2024

Figure 17. Global Top Next-Generation Oncology Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Oncology Solution as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Next-Generation Oncology Solution Revenue in 2024

Figure 19. North America Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Next-Generation Oncology Solution Market Share by Country (2020-2031)

Figure 21. United States Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Next-Generation Oncology Solution Market Share by Country (2020-2031)

Figure 25. Germany Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Next-Generation Oncology Solution Market Share by Region (2020-2031)

Figure 33. China Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Next-Generation Oncology Solution Market Share by Country (2020-2031)

Figure 41. Mexico Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Next-Generation Oncology Solution Market Share by Country (2020-2031)

Figure 45. Turkey Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Next-Generation Oncology Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Illumina Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 49. PerkinElmer Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 51. Roche Holding Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 52. Agilent Technologies Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 53. Paige Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 54. GE Healthcare Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 55. Varian Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 56. Brainlab Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 57. Qiagen Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 58. Hologic Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 59. Pacific Biosciences Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 60. AstraZeneca Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 61. BGI Group Revenue Growth Rate in Next-Generation Oncology Solution Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Clinical Oncology Next Generation Sequencing Market Research Report 2024

Global Genomics Solutions Market Research Report 2024

Next Generation Sequencing NGS Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Cancer Diagnostics Market

Oncology Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intelligent Radiotherapy Overall Solution Market Research Report 2024

Global Next Generation Ultrasound Systems Market Insights Forecast to 2030

Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Breast Cancer Diagnostic Technologies Market Insights Forecast to 2030

Global Oncology EMR Software Market Insights Forecast to 2030

Global Next Generation Sequencing Technology Market Research Report 2025

Global Next Generation Sequencing Data Analysis Market Research Report 2024

Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Small Molecule Drugs Market Insights Forecast to 2030

Global Next Generation Oncology Devices Market Research Report 2024

Global Oncology Clinical Imaging Solutions Market Research Report 2025

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global Personalized Medicines In Oncology Market Research Report 2024

Global Next Generation IVD Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions